Effects of Walking in Greenspace and the Built Environment in Adults With Prediabetes: A Randomized Crossover Trial

NCT06365723 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2025-09-22

No results posted yet for this study

Summary

The goal of this randomized crossover trial is to compare the differences in psychological and physiological effects of walking in two different outdoor environments (urban/suburban commercial environments vs. urban/suburban nature areas/preserves) in adults with prediabetes. The main questions it aims to answer are:

* Do psychological measures of stress, anxiety, and affect improve more in one type of outdoor environment over the other?
* Do physiological measures of stress improve more in one type of outdoor environment over the other?

As this is a crossover trial, participants will serve as their own controls. Researchers will compare both the psychological and physiological effects walking in the two types of outdoor environments.

Participants will:

* Walk 150-minutes per week for six weeks in each of the two outdoor conditions.
* Visit the clinic four times, including before and after each six-week walking period.
* Collect saliva samples immediately proceeding or following the four clinic visits.
* Return to their pre-study level of physical activity for a 5-week washout period between each of the two walking interventions.

Conditions

  • PreDiabetes
  • Heart Rate Variability (HRV)
  • Stress and Anxiety
  • Stress Biomarkers

Interventions

BEHAVIORAL

Nature-based Walking

All participants will be asked to walk three to five times per week for 30-50 minutes per walk, totaling 150 min/week, at moderate intensity over a 6-week period in a designated nature-based, or 'green', urban environment.

BEHAVIORAL

Built-environment/Commercial Walking

All participants will be asked to walk three to five times per week for 30-50 minutes per walk, totaling 150 min/week, at moderate intensity over a 6-week period in a designated built-environment/commercial, or 'Gray', urban environment.

Sponsors & Collaborators

Principal Investigators

  • Mark Pereira, PhD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-06
Primary Completion
2027-11-30
Completion
2027-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06365723 on ClinicalTrials.gov